Krishnan promoted to president and head of R&D at OncoNano

OncoNano Medicine Inc. promoted Kartik Krishnan to the new role of president and head of R&D from CMO. Before joining OncoMed in 2022, Krishnan was CMO at Arcus Biosciences Inc. (NYSE:RCUS). OncoNano is developing a pH-sensitive polymeric micelle technology to diagnose and treat solid tumors.

Inflammatory and immuno-oncology company Hudson Therapeutics Inc. named Janice McCourt as co-CEO and a board member. In her role as co-CEO, McCourt will be responsible for the business development division, with a focus on research collaborations and licensing deals.  She was CBO at Comera Life Sciences Holdings Inc. (NASDAQ:CMRA)...